MANNITOL 20%- mannitol injection
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Mannitol Injection 20% is indicated for use as an osmotic diuretic in canine species. Mannitol is essentially inert metabolically. When given parenterally, it is freely filtered at the glomerulus which produces osmotic diuresis as more than 90% of the mannitol injected escapes reabsorption.
Mannitol USP……………………………..20 g
Water for Injection………………………q.s.
This solution contains 1098 m0smols/Liter
The usual canine dosage administered intravenously is 1.5 — 2.0 g per Kg body weight given over a 30 minute period. This is approximately 3.4-4.5 mL/lb of body weight.
Crystals of mannitol may form in a 20% saturated solution of mannitol. Dissolve the crystals by warming in hot water or autoclaving for 15 minutes. Cool to body temperature before administering. This is a single dose vial that contains no preservatives. Use entire contents when first opened.
Store at temperatures between 15°and 30°C (59°-86°F)
Manufactured by: Nova-Tech, Inc. Grand Island, NE 68801 for Neogen Corporation
Boise, ID 83705
Made in USA
Net Contentes: 100 mL
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FOR ANIMAL USE ONLY
KEEP OUT OF THE REACH OF CHILDREN
| MANNITOL 20%
|Labeler — MWI (VetOne) (019926120)|
|Registrant — Nova-Tech, Inc (196078976)|
Revised: 11/2019 MWI (VetOne)
VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.